These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11994761)

  • 1. CD44 variant exons in leukemia and lymphoma.
    Akisik E; Bavbek S; Dalay N
    Pathol Oncol Res; 2002; 8(1):36-40. PubMed ID: 11994761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia.
    Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
    Hematol Oncol; 1998 Dec; 16(4):131-41. PubMed ID: 10414233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease.
    Takazoe K; Foti R; Tesch GH; Hurst LA; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Clin Exp Immunol; 2000 Sep; 121(3):523-32. PubMed ID: 10971520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
    Bendall LJ; Bradstock KF; Gottlieb DJ
    Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD44 variants in osteosarcoma.
    Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H
    J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations.
    Weber B; Rösel M; Arch R; Möller P; Zöller M
    Differentiation; 1996 Mar; 60(1):17-29. PubMed ID: 8935925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of CD44v6/v7 in acute promyelocytic leukemia.
    Chen P; Huang HF; Lu R; Wu Y; Chen YZ
    Asian Pac J Cancer Prev; 2012; 13(8):3791-4. PubMed ID: 23098472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 expression in soft tissue sarcomas.
    Kahara N; Ozaki T; Doi T; Nishida K; Kawai A; Shibahara M; Inoue H
    Virchows Arch; 2000 Jun; 436(6):574-8. PubMed ID: 10917171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
    Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy.
    Irving JA; Cain G; Howard M; Angus B; Taylor PR; Cattan AR
    J Clin Pathol; 1998 Oct; 51(10):776-80. PubMed ID: 10023342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation.
    Khan SA; Cook AC; Kappil M; Günthert U; Chambers AF; Tuck AB; Denhardt DT
    Clin Exp Metastasis; 2005; 22(8):663-73. PubMed ID: 16691370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
    Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
    J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44.
    Yu Q; Toole BP
    J Biol Chem; 1996 Aug; 271(34):20603-7. PubMed ID: 8702806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease.
    van Driel M; Günthert U; Stauder R; Joling P; Lokhorst HM; Bloem AC
    Leukemia; 1998 Nov; 12(11):1821-8. PubMed ID: 9823960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.
    Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F
    Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression.
    Khaldoyanidi S; Achtnich M; Hehlmann R; Zöller M
    Leuk Res; 1996 Oct; 20(10):839-51. PubMed ID: 8960109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 variant isoforms in head and neck squamous cell carcinoma progression.
    Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY
    Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
    Ermak G; Jennings T; Robinson L; Ross JS; Figge J
    Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer.
    Tokumo K; Kodama J; Seki N; Miyagi Y; Yoshinouchi M; Kudo T
    Eur J Cancer; 1998 Dec; 34(13):2107-11. PubMed ID: 10070319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
    Jackson DG; Bell JI; Dickinson R; Timans J; Shields J; Whittle N
    J Cell Biol; 1995 Feb; 128(4):673-85. PubMed ID: 7532175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.